We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Synacthen tetracosactide 250mcg/mL solution for injection (UK)
Section 19A approved medicine
(Approval lapsed) Synacthen tetracosactide 250mcg/mL solution for injection (UK)
Section 19A approval holder
Clinect Pty Ltd ABN 76 150 558 473
Phone
1899 899 005
Approved until
Status
Expired
Medicines in short supply/unavailable
SYNACTHEN tetracosactide (tetracosactrin) 0.25mg/1mL injection ampoule ARTG- 11058
Indication(s)
As a diagnostic aid in the assessment of suspected adrenocortical hypofunction.